We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.4B
1-Year Est. Return 18.8%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+18.8%
3 Year Est. Return
+75.86%
5 Year Est. Return
+92.86%
10 Year Est. Return
+306.51%
AUM
$2.4B
AUM Growth
+$98M
Cap. Flow
+$49.1M
Cap. Flow %
2.05%
Top 10 Hldgs %
33.05%
Holding
1,196
New
102
Increased
276
Reduced
229
Closed
65

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$7M
2
UNP icon
Union Pacific
UNP
+$3.41M
3
CMCSA icon
Comcast
CMCSA
+$2.06M
4
BDX icon
Becton Dickinson
BDX
+$1.63M
5
HON icon
Honeywell
HON
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 25.48%
2 Financials 13.75%
3 Healthcare 9.26%
4 Communication Services 8.92%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AES icon
901
AES
AES
$10.5B
$6.34K ﹤0.01%
+442
New +$6.23K
LYB icon
902
LyondellBasell Industries
LYB
$20B
$6.24K ﹤0.01%
144
WTM icon
903
White Mountains Insurance
WTM
$5.2B
$6.23K ﹤0.01%
3
JBHT icon
904
JB Hunt Transport Services
JBHT
$25.5B
$6.22K ﹤0.01%
32
CCL icon
905
Carnival Corporation Ltd
CCL
$38.1B
$6.14K ﹤0.01%
201
EQH icon
906
Equitable Holdings
EQH
$13B
$6.05K ﹤0.01%
127
SPH icon
907
Suburban Propane Partners
SPH
$1.24B
$5.97K ﹤0.01%
322
NTAP icon
908
NetApp
NTAP
$35B
$5.89K ﹤0.01%
55
-18
-25% -$2.06K
GL icon
909
Globe Life
GL
$14.2B
$5.87K ﹤0.01%
+42
New +$5.69K
AVEM icon
910
Avantis Emerging Markets Equity ETF
AVEM
$25.4B
$5.78K ﹤0.01%
+75
New +$5.74K
TAK icon
911
Takeda Pharmaceutical
TAK
$54.6B
$5.77K ﹤0.01%
370
HLN icon
912
Haleon
HLN
$43.5B
$5.69K ﹤0.01%
563
+363
+182% +$3.45K
RKT icon
913
Rocket Companies
RKT
$36.5B
$5.69K ﹤0.01%
294
MSSM
914
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSM
$710M
$5.67K ﹤0.01%
+112
New +$5.73K
COIN icon
915
Coinbase
COIN
$38.6B
$5.65K ﹤0.01%
25
BGC icon
916
BGC Group
BGC
$5.45B
$5.63K ﹤0.01%
630
-1,530
-71% -$13.8K
IFF icon
917
International Flavors & Fragrances
IFF
$20.2B
$5.59K ﹤0.01%
83
ALNY icon
918
Alnylam Pharmaceuticals
ALNY
$27.5B
$5.57K ﹤0.01%
14
CC icon
919
Chemours
CC
$2.5B
$5.53K ﹤0.01%
469
JKHY icon
920
Jack Henry & Associates
JKHY
$10.9B
$5.47K ﹤0.01%
30
CFLT
921
DELISTED
Confluent
CFLT
$5.44K ﹤0.01%
180
WDAY icon
922
Workday
WDAY
$39.6B
$5.37K ﹤0.01%
25
+7
+39% +$1.59K
STAG icon
923
STAG Industrial
STAG
$7.38B
$5.33K ﹤0.01%
145
TWO
924
Two Harbors Investment
TWO
$1.27B
$5.31K ﹤0.01%
506
CELH icon
925
Celsius Holdings
CELH
$7.47B
$5.21K ﹤0.01%
114

Similar funds

Trust Company of Vermont's Q4 2025 Portfolio in Review

As of Q4 2025, Trust Company of Vermont held 1,196 positions worth $2.4B, up 4.3% from $2.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trust Company of Vermont's Q4 2025 filing shows 102 new, 276 increased, 229 reduced and 65 closed positions. Its largest new stake was Vertiv: 1,604 shares worth $260K. The largest sale was Accenture, an estimated $7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q4 2025 buy was Vertiv: 1,604 shares worth $260K.
  • Trust Company of Vermont added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q4 2025, an estimated $14.1M increase.
  • Trust Company of Vermont's biggest Q4 2025 reduction was Accenture, cutting an estimated $7M.
  • Trust Company of Vermont fully exited Kellanova in Q4 2025, selling an estimated $341K.
  • Trust Company of Vermont's ten largest holdings make up 33% of its $2.4B portfolio in Q4 2025.
  • Trust Company of Vermont opened 102 new positions and closed 65 in Q4 2025.
  • Trust Company of Vermont's portfolio value rose 4.3% quarter-over-quarter to $2.4B.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.